| |
HIV + DM2+
|
HIV + DM2-
|
Controls with DM2
|
Healthy controls
|
P
|
|---|
|
Adiponectin (μg/mL)
|
9.79 (8.02–11.56)
|
13.83 (10.07–17.06)*
|
8.63 (6.96–10.29)
|
14.96 (12.80–17.11)*
|
< 0.001
|
|
IL-6 (pg/mL)
|
2.16 (1.16–3.15)
|
1.04 (0.67–1.41)*
|
3.89 (0.89–8.66)
|
0.91 (0.72–1.11)*
|
0.050
|
|
TNF-alfa (pg/mL)
|
3.24 (2.66–3.82)
|
2.92 (2.01–3.84)
|
4.02 (1.32–6.73)
|
2.29 (2.07–2.51)
|
0.112
|
|
sCD14 (ng/mL)
|
2333 (1935–2732)
|
2218 (1912–2525)
|
1461 (1277–1644)*
|
1504 (1302–1706)*
|
< 0.001
|
- Soluble markers presented as mean (95%CI) before log transformation. P-value represent one-way ANOVA analyses after log transformation followed by t-test for comparison between HIV + DM2+ and the 3 control groups when ANOVA test was *p < 0.05 compared to HIV+DM2+
- Abbreviations: HIV + DM2+ People living with HIV with diabetes mellitus type 2, HIV + DM2- People living with HIV without diabetes mellitus type 2, IL-6 Interleukin-6, TNF- α Tumor necrosis factor-alfa, sCD14 Soluble CD14, DM2 Diabetes mellitus type 2
